Primer H-TB

Hazard statements (CLP)

H225, H315, H317, H319, H334, H336, H373

Code

Statements

H225

Highly Flammable liquid and vapour

EU Classification

Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations

Physical hazards

Flammable liquids, Category 2 H225 Highly flammable liquid and vapour.

Health hazards

Skin corrosion/irritation, Category 2 H315 Causes skin irritation. Serious eye damage/eye irritation, H319 Causes serious eye irritation. Category 2 Respiratory sensitisation, Category 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitisation, Category 1 H317 May cause an allergic skin reaction. Specific target organ toxicity – Single H336 May cause drowsiness or dizziness. exposure, Category 3, Narcosis Specific target organ toxicity – H373 May cause damage to organs through Repeated exposure, Category 2 prolonged or repeated exposure. Full text of H- and EUH-statements: see section 16

Adverse physicochemical, human health and environmental effects

No additional information available

2.2 Label elements

Labelling according to The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations

Signal word

Danger

Contains

1,3-Benzenedicarboxylic acid, polymer with 1,4-benzenedicarboxylic acid, 1,6- diisocyanatohexane, 2,2-dimethyl-1,3-propanediol and 1,3-ethandiol, Benzene, 1,3- diisocyanatomethyl-, homopolymer, Benzene, 2,4-diisocyanato-1-methyl-, homopolymer, 4- isocyanatosulphonyltoluene

Hazard statements

H225 Highly flammable liquid and vapour. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H336 May cause drowsiness or dizziness. H373 May cause damage to organs through prolonged or repeated exposure.

Prevention

P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P260 Do not breathe fume, gas, mist, spray, vapours. P280 Wear protective clothing, eye protection, face protection, protective gloves.

Response

P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER, doctor. P370+P378 In case of fire: Use D-powder, carbon dioxide (CO2), foam to extinguish.

Storage

P403+P235 Store in a well-ventilated place. Keep cool.

Additional information

As from 24 August 2023 adequate training is required before industrial or professional use.

Other hazards which do not result in classification

Gas/vapour heavier than air. May accumulate in confined spaces, particularly at or below ground level. Persons already sensitised to diisocyanates may develop allergic reactions when using this product. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII. This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII. The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %